[1]
“Formulation and Characterization of Ondansetron Hydrochloride Matrix Tablets for Sustained Drug Delivery”, Int. J. Pharm. Sci. Drug Res., vol. 11, no. 4, pp. 147–151, Jul. 2019, doi: 10.25004/IJPSDR.2019.110408.